Muscle and plasma coenzyme Q10 concentration, aerobic power and exercise economy of healthy men in response to four weeks of supplementation

Journal of Sports Medicine and Physical Fitness

Volumn 45, Issue 3, 2005, Pages 337-346

  Zhou, S ^a   Zhang, Y ^b   Davie, A ^a   Marshall Gradisnik, S ^a   Hu, H ^b   Wang, J ^a   Brushett, D ^a  

^a SOUTHERN CROSS UNIVERSITY   (Australia)

^b TIANJIN UNIVERSITY OF SPORT   (China)

Author keywords

Oxidative phosphorylation; Oxygen consumption; Ubiquinol; Ventilatory threshold

Indexed keywords

ALPHA TOCOPHEROL; PLACEBO; UBIDECARENONE;

ADULT; AEROBIC CAPACITY; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME BLOOD LEVEL; EXERCISE; EXHAUSTION; HUMAN; HUMAN TISSUE; LUNG VENTILATION; MALE; MUSCLE BIOPSY; MUSCLE LEVEL; NORMAL HUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; SINGLE BLIND PROCEDURE; SUPPLEMENTATION; VASTUS LATERALIS MUSCLE;

ADULT; DIETARY SUPPLEMENTS; EXERCISE; EXERCISE TEST; HUMANS; MALE; MUSCLES; OXYGEN CONSUMPTION; PROSPECTIVE STUDIES; QUADRICEPS MUSCLE; TIME FACTORS; UBIQUINONE; VITAMIN E;

EID: 28544437875     PISSN: 00224707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. 10. J Am Coll Nutr 2001;20:591-8.
2. Jones K, Hughes K, Mischley L, McKenna DJ. Coenzyme Q-10: efficacy, safety, and use. Altern Ther Health Med 2002;8:42-55.
3. Niki E. Mechanisms and dynamics of antioxidant action of ubiquinol. Mol Aspects Med 1997;18 Suppl:S63-70.
4. Hackenbrock CR, Chazotte B, Gupte SS. Lateral diffusion of coenzyme Q and redox partners in the control of mitochondrial electron transport. In: Folkers K, Yamamura Y, editors. Biomedical and clinical aspects of coenzyme Q. Amsterdam: Elsevier Science Publishers BV; 1986.p.25-38.
5. Lenaz G, Fato R, Di Bernardo S, Jarreta D, Costa A, Geneva ML et al. Localization and mobility of coenzyme Q in lipid bilayers and membranes. Biofactors 1999;9:87-93.
6. Karlsson J, Lin L, Sylven C, Jansson E. Muscle ubiquinone in healthy physically active males. Mol Cell Biochem 1996;156:169-72.
7. 10: a new drug for cardiovascular disease. J Clin Pharmacol 1990;30:596-608.
8. 10 in chronic heart failure, angina, and hypertension. Pharmacotherapy 2001;21:797-806.
9. Karlsson J, Diamant B, Edlund PO, Lund B, Folkers K, Theorell H. Plasma ubiquinone, alpha-tocopherol and cholesterol in man. Int J Vit Nutr Res 1992;62:160-4.
10. Karlsson J. Antioxidants and exercise. Champaign, IL: Human Kinetics; 1997.
11. 10 supplementation on exercise performance, VO2max, and lipid peroxidation in trained cyclists. Int J Sport Nutr 1991;1:353-65.
12. 10 affect aerobic capacity in endurance athletes? Int J Sport Nutr 1997;7:197-206.
13. 10 and physical performance. In: Folkers K, Yamamura Y, editors. Biomedical and clinical aspects of coenzyme Q. Armsterdam: Elsevier/North-Holland Biomedical Press; 1981.p.235-41.
14. Guerra G, Bargossi A, Fiorella P, Piazzi S. Effect of the administration of ubidecarenone over the maximum consumption of oxygen and on the physical performance in a group of young cyclists. Med Sport (Roma) 1987;40:359-64.
15. 10 treatment in high level athletes. In: Folkers K, Littarru GP, Yamagami T, editors. Biomedical and clinical aspects of coenzyme Q. Amsterdam: Elsevier Science Publishers; 1991.p.513-20.
16. 10) on the metabolic response to work. J Sports Med Phys Fitness 1989;29:57-62.
17. 10 on the exercise performance of cross-country skiers. Mol Aspects Med 1997;18 Suppl:S283-S90.
18. Laaksonen R, Fogelholm M, Himberg JJ, Laakso J, Salorinne Y. Ubiquinone supplementation and exercise capacity in trained young and older men. Eur J Appl Physiol Occup Physiol 1995;72:95-100.
19. Snider IP, Bazzarre TL, Murdoch SD, Goldfarb A. Effects of coenzyme athletic performance system as an ergogenic aid on endurance performance to exhaustion. Int J Sport Nutr 1992;2:272-86.
20. 10 levels and adenine nucleotide catabolism during high-intensity exercise. Int J Sport Nutr 1999;9:166-80.
21. Laaksonen R, Riihimaki A, Laitila J, Martensson K, Tikkanen MJ, Himberg J-J. Serum and muscle tissue ubiquinone levels in healthy subjects. J Lab Clin Med 1995;125:517-21.
22. Bassett DR, Howley ET. Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc 2000;32:70-84.
23. Xu F, Rhodes EC. Oxygen uptake kinetics during exercise. Sports Med 1999;27:313-27.
24. Australian Sports Commission. Physiological tests for elite athletes. Lower Mitcham, South Australia: Human Kinetics; 2000.p.122.
25. Zhou S, Weston S. Reliability of using D-max method to define physiological responses to incremental exercise testing. Physiol Meas 1997;18:145-54.
26. 10 in plasma. J Chromatogr 1992;593:217-26.
27. Bergstrom J. Muscle electrolytes in man. Scand J Clin Invest 1962;14 Suppl:1-110.
28. Brooke MH, Kaiser KK. Three "myosin ATPase" systems: the nature of their pH lability and sulfhydryl dependence. J Histochem Cytochem 1970;18:670-2.
29. Turunen M, Swiezewska E, Chojnacki T, Sindelar P, Dallner G. Regulatory aspects of coenzyme Q metabolism. Free Radic Res 2002;36:437-43.
30. 10 Association. London, UK: http://wwwcsi.unian.it/coenzymeQ/thefirst.html; 2002.p.9.
31. Bonetti A, Solito F, Carmosino G, Bargossi AM, Fiorella PL. Effect of ubidecarenone oral treatment on aerobic power in middle-aged trained subjects. J Sports Med Phys Fitness 2000;40:51-7.
32. Ernster L, Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1995;1:195-204.
33. 10: absorption, antioxidative properties, determinants, and plasma levels. Free Radic Res 2002;36:389-97.
34. 10 and d-alphatocopheryl acetate supplementation on exercise-induced lipid peroxidation and muscular damage: a placebo-controlled double-blind study in marathon runners. Free Radic Res 1998;29:85-92.
35. 2 kinetics during heavy exercise. Med Sci Sports Exerc 1994;26:1327-34.